Rosati R, Ma H, Cabelof D
J Oncol. 2012; 2012:105949.
PMID: 23093960
PMC: 3474250.
DOI: 10.1155/2012/105949.
Schmidt A, Passarge E, Seemanova E, Macek M
Hum Genet. 1982; 62(3):285-6.
PMID: 7169221
DOI: 10.1007/BF00333539.
Steinbach P, Barbi G, Baur S, Vogel W
Hum Genet. 1983; 64(3):279-82.
PMID: 6885072
DOI: 10.1007/BF00279411.
Fonatsch C, Schwinger E
Hum Genet. 1983; 64(1):39-41.
PMID: 6683707
DOI: 10.1007/BF00289476.
Steinbach P, Barbi G, Baur S, Wiedenmann A
Hum Genet. 1983; 63(4):404-5.
PMID: 6683244
DOI: 10.1007/BF00274770.
Intracellular folate distribution in cultured fibroblasts from patients with the fragile X syndrome.
Popovich B, Rosenblatt D, Cooper B, Vekemans M
Am J Hum Genet. 1983; 35(5):869-78.
PMID: 6614003
PMC: 1685829.
Autosomal fragile sites and cancer.
Hecht F, Hecht B
Am J Hum Genet. 1984; 36(3):718-20.
PMID: 6428224
PMC: 1684443.
The fragile X syndrome: the patients and their chromosomes.
De Arce M, Kearns A
J Med Genet. 1984; 21(2):84-91.
PMID: 6371234
PMC: 1049231.
DOI: 10.1136/jmg.21.2.84.
Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.
NIELSEN K, Tommerup N
Hum Genet. 1984; 66(2-3):225-9.
PMID: 6232199
DOI: 10.1007/BF00286606.
Thymidylate synthetase inhibitors and fragile site expression in lymphocytes.
Jacky P, Sutherland G
Am J Hum Genet. 1983; 35(6):1276-83.
PMID: 6228136
PMC: 1685952.
The combined effects of FUdR addition and methionine depletion on the X-chromosome fragile site.
Glover T
Am J Hum Genet. 1983; 35(1):117-22.
PMID: 6218753
PMC: 1685483.
Fragile X syndrome: clinical, cytogenetic, biochemical and molecular features.
Mixon J, Dev V
Indian J Pediatr. 1986; 53(4):451-9.
PMID: 3804387
DOI: 10.1007/BF02749526.
Improved technique for the expression of fragile-X in cultured amniotic fluid cells.
von Koskull H, AULA P, Ammala P, Nordstrom A, Rapola J
Hum Genet. 1985; 69(3):218-23.
PMID: 3156804
DOI: 10.1007/BF00293028.
The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome.
Vandamme B, Liebaers I, Hens L, Bernheim J, Roobol C
Hum Genet. 1988; 79(4):341-6.
PMID: 2970425
DOI: 10.1007/BF00282173.
Induction of fragile sites in fibroblasts.
Sutherland G, Baker E
Am J Hum Genet. 1986; 38(4):573-5.
PMID: 2939714
PMC: 1684789.
Induction of the fragile X on BrdU-substituted chromosomes with direct visualization of sister chromatid exchanges on banded chromosomes.
Tommerup N
Hum Genet. 1989; 81(4):377-81.
PMID: 2703242
DOI: 10.1007/BF00283696.
Improved fragile site detection with trimethoprim.
McLean D, FAED M
Hum Genet. 1990; 85(2):241-3.
PMID: 2370056
DOI: 10.1007/BF00193204.
Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine.
MacGregor J, Schlegel R, Wehr C, Alperin P, Ames B
Proc Natl Acad Sci U S A. 1990; 87(24):9962-5.
PMID: 2263647
PMC: 55294.
DOI: 10.1073/pnas.87.24.9962.
X chromosome imprinting in fragile X syndrome.
Yu W, Wenger S, STEELE M
Hum Genet. 1990; 85(6):590-4.
PMID: 2227950
DOI: 10.1007/BF00193580.
